Advanced glycosylation end products in patients with diabetic nephropathy.
about
Molecular characterization of mammalian dicarbonyl/L-xylulose reductase and its localization in kidneyAdvanced glycation end products are eliminated by scavenger-receptor-mediated endocytosis in hepatic sinusoidal Kupffer and endothelial cellsImmunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patientsbeta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosisTobacco smoke is a source of toxic reactive glycation productsDoes accumulation of advanced glycation end products contribute to the aging phenotype?Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathyAssessment of bone turnover and bone quality in type 2 diabetic bone disease: current concepts and future directionsMicroRNAs in Diabetic Nephropathy: From Biomarkers to TherapyImmune dysfunction in uremia—an updateDiabetic kidney disease; review of the current knowledgeLow levels of serum soluble receptors for advanced glycation end products, biomarkers for disease state: myth or realityArterial stiffness, vascular calcification and bone metabolism in chronic kidney diseaseLoss of CD4 T-cell-dependent tolerance to proteins with modified amino acidsSimple non-invasive assessment of advanced glycation endproduct accumulationAGEs, autofluorescence and renal functionAdvanced glycation end products in human optic nerve headBeyond genetic factors in familial amyloidotic polyneuropathy: protein glycation and the loss of fibrinogen's chaperone activityAdvanced Glycation Endproducts and Bone Material Properties in Type 1 Diabetic MiceInhibitory effect of receptor for advanced glycation end products (RAGE) on the TGF-β-induced alveolar epithelial to mesenchymal transitionEvolving pandemic diabetic nephropathyGuidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus.Association between serum 2-microglobulin level and infectious mortality in hemodialysis patients.Advanced glycation end products induce tubular epithelial-myofibroblast transition through the RAGE-ERK1/2 MAP kinase signaling pathwayAdvanced glycation end products: a highly complex set of biologically relevant compounds detected by mass spectrometry.Microvascular changes in the diabetic foot.Proteomics reveals novel oxidative and glycolytic mechanisms in type 1 diabetic patients' skin which are normalized by kidney-pancreas transplantation.Tissue-advanced glycation end product concentration in dialysis patients.Serum carboxymethyl-lysine, a dominant advanced glycation end product, is associated with chronic kidney disease: the Baltimore longitudinal study of aging.Advanced glycation end-products induce tubular CTGF via TGF-beta-independent Smad3 signaling.SOCS3 overexpression inhibits advanced glycation end product-induced EMT in proximal tubule epithelial cellsPyridine nucleotides in glucose metabolism and diabetes: a review.Diet and Diabetic Kidney Disease: Plant Versus Animal Protein.Attenuation of diabetic nephropathy in streptozotocin-induced diabetic rats by Punica granatum Linn. leaves extractSkin fluorescence correlates strongly with coronary artery calcification severity in type 1 diabetes.Peer support for patients with type 2 diabetes in rural communities of China: protocol for a cluster randomized controlled trial.Increased collagen-linked pentosidine levels and advanced glycosylation end products in early diabetic nephropathy.Neurotoxicity of advanced glycation endproducts during focal stroke and neuroprotective effects of aminoguanidineThe AGE-receptor in the pathogenesis of diabetic complications.Therapeutic potential of AGE inhibitors and breakers of AGE protein cross-links.
P2860
Q24292412-429D6F99-E917-4AFA-8605-EBC1DF98B4F6Q24530074-B68EBA8B-EB34-449F-84B1-1C630C9632C8Q24561776-7F872493-881E-4381-8D03-F466A7EAA462Q24597379-A75ACB83-2CB9-4175-B771-22EA1DA8F478Q24623337-E1FBA175-F41D-408F-9F87-73C617AC9409Q24632710-916D00EA-291B-4CA6-93E5-6EC9BD082B58Q24682750-9C5D0966-3B8C-4F37-BB90-1AE8636874FCQ26750574-C0487575-6464-4A7F-AE81-756D95540A06Q26766102-261F5876-3067-41CC-8194-3E1CB83E7198Q26829076-892F92D5-4781-4523-8871-8001CD756210Q26830565-F798837C-B4F5-4A5E-929F-8052DAB11BB1Q26859793-A6DBAE81-9999-4668-B06D-036F6DC2372AQ27024623-33308332-299E-4BB7-8578-A7309820F3A4Q28243525-5A56728E-8B03-4554-8A0E-9C4DBC706593Q28271097-934597D6-2CB0-4379-9C25-BA7BDE88AFD8Q28301793-3F07F2AE-CCCF-4433-909A-C7F1089E09CEQ28345352-D8137DBC-02E1-43C3-808E-591B069777E7Q28477682-07B8FB25-5E03-4D47-AB97-713AE3601897Q28551744-D76C260A-6BB6-466C-89EF-0C05676FB6DDQ29346955-C6D4136D-B352-4032-BE5B-A45FEF0424A5Q30352538-55CB5B36-D7A4-4538-85C4-19827EF01A4BQ30426632-A0F27048-5A21-4739-98E4-95B5697AF016Q30440532-A61BE1D3-FA1F-4462-BDC6-B4870669BFBAQ30445160-DC6AFC4E-9913-489D-9C2C-C7CA8D45881BQ30665222-4843794F-B95A-410D-852A-7E0006336CBDQ33255016-74B495D9-8FAB-4B9D-8DDF-4E36DD32F42DQ33548694-666BBEFD-289B-4E40-A0A1-95B80912BBFAQ33571288-3580814A-715F-49A1-872B-50787B7EC5BCQ33691339-388EEA81-52F6-46B6-9EF5-244281AE5E65Q33711306-63509FB8-CDD0-4C39-9102-C7838CBD23BAQ33744838-C654F3A1-81B4-48C1-9353-9E741A897E5CQ33856582-A1848B17-FEC1-4817-9DB7-DEE6535C3D29Q33889472-8EB219B1-FD57-4B91-8563-1FC490954FECQ33896502-40BC92F9-2400-43BF-A4C1-53A883958091Q33905029-434A542D-46DE-437F-84E2-26DE04617412Q34045318-77BB483E-09CE-4A60-B015-DA6DDF541C36Q34111608-6E4DEC78-3D70-40F8-B5D1-EB0764692EC6Q34374197-8DFD2E4E-2BB3-4D2A-8FCD-178F73B9EC6AQ34470639-E1EFEE59-2177-44C3-82B6-EC1D2ABEA660Q34481838-43DE866B-0CB1-412B-A3B0-336B7D0492CA
P2860
Advanced glycosylation end products in patients with diabetic nephropathy.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh
1991年學術文章
@zh-hant
name
Advanced glycosylation end products in patients with diabetic nephropathy.
@en
Advanced glycosylation end products in patients with diabetic nephropathy.
@nl
type
label
Advanced glycosylation end products in patients with diabetic nephropathy.
@en
Advanced glycosylation end products in patients with diabetic nephropathy.
@nl
prefLabel
Advanced glycosylation end products in patients with diabetic nephropathy.
@en
Advanced glycosylation end products in patients with diabetic nephropathy.
@nl
P2093
P1476
Advanced glycosylation end products in patients with diabetic nephropathy.
@en
P2093
Friedman EA
Rayfield EJ
Vlassara H
P304
P356
10.1056/NEJM199109193251202
P407
P577
1991-09-01T00:00:00Z